Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update

Recent Safety Concerns With Proton Pump Inhibitors

(2012) Joan Chen et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

A Randomized, 2-Period, Crossover Design Study to Assess the Effects of Dexlansoprazole, Lansoprazole, Esomeprazole, and Omeprazole on the Steady-State Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers

(2012) Andrew L. Frelinger et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Accumulating Evidence for a Drug-Drug Interaction Between Methotrexate and Proton Pump Inhibitors

(2012) S. Bezabeh et al.   ONCOLOGIST

Effects of Proton Pump Inhibitors on Platelet Function in Patients Receiving Clopidogrel

(2011) Chun Shing Kwok et al.   DRUG SAFETY

Proton Pump Inhibitor Co-therapy With Clopidogrel: Is There GI Benefit or Cardiovascular Harm?

(2011) Loren Laine   GASTROENTEROLOGY

The proton pump inhibitor pantoprazole and its interaction with enteric-coated mycophenolate sodium in transplant recipients

(2011) Sieglinde Kofler et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Clopidogrel–Drug Interactions

(2011) Eric R. Bates et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The potential interaction between clopidogrel and proton pump inhibitors: a systematic review

(2010) Joao Paulo de Aquino Lima et al.   BMC Medicine

Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers

(2010) Adriana Rocha et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Drug-Drug Interaction Profiles of Proton Pump Inhibitors

(2010) Ryuichi Ogawa et al.   CLINICAL PHARMACOKINETICS

Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies

(2010) D J Angiolillo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Effect of Acid Reduction With a Proton Pump Inhibitor on the Pharmacokinetics of Lopinavir or Ritonavir in HIV-Infected Patients on Lopinavir/Ritonavir-Based Therapy

(2010) Edgar T. Overton et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil

(2010) M. Schaier et al.   RHEUMATOLOGY

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

(2009) D. N. Juurlink et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Effects of Omeprazole on Plasma Levels of Raltegravir

(2009) Marian Iwamoto et al.   CLINICAL INFECTIOUS DISEASES

Effect of the Cytochrome P450 2C19 Inhibitor Omeprazole on the Pharmacokinetics and Safety Profile of Bortezomib in Patients with Advanced Solid Tumours, Non-Hodgkinʼs Lymphoma or Multiple Myeloma

(2009) David I. Quinn et al.   CLINICAL PHARMACOKINETICS

Absence of Influence of Concomitant Administration of Rabeprazole on the Pharmacokinetics of Tacrolimus in Adult Living-donor Liver Transplant Patients: A Case–control Study

(2009) Keiko Hosohata et al.   Drug Metabolism and Pharmacokinetics

The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease

(2009) M. Wurtz et al.   HEART

Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome

(2009) P. Michael Ho   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Do Proton Pump Inhibitors Attenuate the Effect of Aspirin on Platelet Aggregation? A Randomized Crossover Study

(2009) Adam B Adamopoulos et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Bioavailability of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium Is Differentially Affected by Pantoprazole in Healthy Volunteers

(2009) Korbinian Rupprecht et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Proton Pump Inhibitor Co-medication Reduces Mycophenolate Acid Drug Exposure in Heart Transplant Recipients

(2009) Sieglinde Kofler et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Effect of omeprazole on the plasma concentrations of indinavir when administered alone and in combination with ritonavir

(2008) H. L. Tappouni et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers

(2008) Monika Schöller-Gyüre et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Drug Interaction Studies with Dexlansoprazole Modified Release (TAK-390MR), a Proton Pump Inhibitor with a Dual Delayed-Release Formulation

(2008) Majid Vakily et al.   CLINICAL DRUG INVESTIGATION

Prokinetics Influence the Pharmacokinetics of Rabeprazole

(2008) Katsuhito Arai et al.   DIGESTION

Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel

(2008) David S. Small et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The Role of Cytochrome P2C19 in R-warfarin Pharmacokinetics and its Interaction With Omeprazole

(2008) Tsukasa Uno et al.   THERAPEUTIC DRUG MONITORING

Significant Decrease in Nelfinavir Systemic Exposure After Omeprazole Coadministration in Healthy Subjects

(2007) Annie F Fang et al.   PHARMACOTHERAPY